本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Zevra Therapeutics

11.65
-0.4000-3.32%
盤後11.650.00000.00%19:42 EDT
成交量:91.66萬
成交額:1,073.90萬
市值:6.89億
市盈率:12.13
高:12.34
開:12.34
低:11.52
收:12.05
52周最高:15.04
52周最低:7.16
股本:5,911.49萬
流通股本:5,385.99萬
量比:1.16
換手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):0.9602
每股收益(LYR):1.35
淨資產收益率:34.80%
總資產收益率:8.74%
市淨率:3.16
市盈率(LYR):8.63

資料載入中...

2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

重要事件披露

Form 8-K - Current report
2026/03/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

重要事件披露

Form 8-K - Current report
2026/03/09

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities